A. Milner

585 total citations
24 papers, 398 citations indexed

About

A. Milner is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, A. Milner has authored 24 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 5 papers in Surgery. Recurrent topics in A. Milner's work include Gastric Cancer Management and Outcomes (6 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Treatment and Pharmacology (3 papers). A. Milner is often cited by papers focused on Gastric Cancer Management and Outcomes (6 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer Treatment and Pharmacology (3 papers). A. Milner collaborates with scholars based in Australia, United Kingdom and United States. A. Milner's co-authors include Samuel Y. Ngan, John Mackay, Alexander G. Heriot, Trevor Leong, Rodney J. Hicks, Elizabeth Drummond, Annette Hogg, H. Miles Prince, David Ritchie and Stephen Hughes and has published in prestigious journals such as Journal of Clinical Oncology, The British Journal of Psychiatry and British Journal of Cancer.

In The Last Decade

A. Milner

23 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Milner Australia	11	154	145	141	56	53	24	398
Fazıl Aydin Türkiye	11	77 0.5×	88 0.6×	132 0.9×	37 0.7×	27 0.5×	32	345
Vincent Verschaeve Belgium	9	94 0.6×	147 1.0×	112 0.8×	22 0.4×	100 1.9×	21	389
Richard Mansour United States	9	43 0.3×	71 0.5×	152 1.1×	62 1.1×	39 0.7×	56	326
C. Cruickshank United Kingdom	6	113 0.7×	123 0.8×	129 0.9×	11 0.2×	20 0.4×	11	370
L.L. Siu Canada	7	171 1.1×	169 1.2×	176 1.2×	26 0.5×	14 0.3×	21	438
Julie Huang United States	10	160 1.0×	106 0.7×	57 0.4×	15 0.3×	33 0.6×	19	435
Ettinger Ds United States	12	73 0.5×	126 0.9×	170 1.2×	17 0.3×	20 0.4×	21	429
Yuhsin V. Wu United States	9	183 1.2×	276 1.9×	107 0.8×	14 0.3×	10 0.2×	16	518
C. van Groeningen Netherlands	8	247 1.6×	205 1.4×	153 1.1×	39 0.7×	14 0.3×	13	463
Irene Chong United Kingdom	8	113 0.7×	46 0.3×	151 1.1×	8 0.1×	22 0.4×	24	311

Countries citing papers authored by A. Milner

Since Specialization

Citations

This map shows the geographic impact of A. Milner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Milner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Milner more than expected).

Fields of papers citing papers by A. Milner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Milner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Milner. The network helps show where A. Milner may publish in the future.

Co-authorship network of co-authors of A. Milner

This figure shows the co-authorship network connecting the top 25 collaborators of A. Milner. A scholar is included among the top collaborators of A. Milner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Milner. A. Milner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Farooq, Saeed, Miriam Hattle, Tom Kingstone, et al.. (2024). Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT). The British Journal of Psychiatry. 225(3). 379–388. 3 indexed citations

Wen, Ping, Jan Drappatz, R. Jena, et al.. (2024). Safety and Preliminary Efficacy of AZD1390 + Radiation Therapy for Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 120(2). S119–S120. 4 indexed citations

Farooq, Saeed, et al.. (2024). Early Intervention in Psychosis and Management of First Episode Psychosis in Low- and Lower-Middle-Income Countries: A Systematic Review. Schizophrenia Bulletin. 50(3). 521–532. 4 indexed citations

Wu, Yi‐Long, Byoung Chul Cho, Qing Zhou, et al.. (2018). MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC. Journal of Thoracic Oncology. 13(10). S358–S359. 1 indexed citations

Dalvi, Tapashi, Karen A. Gelmon, Rebecca Dent, et al.. (2017). BREAKOUT: A cross-sectional, prospective, observational study of germline BRCA mutation (gBRCAm) prevalence and real-world outcomes among patients (pts) with HER2-negative (HER2-ve) metastatic breast cancer (mBC). Annals of Oncology. 28. v105–v105.

Pujade-Lauraine, Éric, Nicoletta Colombo, Rosalind Glasspool, et al.. (2017). OReO/ENGOT Ov-38: A phase IIIb trial of olaparib maintenance retreatment in patients with epithelial ovarian cancer. Annals of Oncology. 28. v351–v352. 13 indexed citations

Naing, Aung, Philip Komarnitsky, A. Milner, et al.. (2012). 608 Phase I Dose-escalation Trial of a Selective Oral MEK1/2 Inhibitor, Pimasertib (MSC1936369B), Combined with an mTOR Inhibitor, Temsirolimus, in Patients with Advanced Solid Tumors. European Journal of Cancer. 48. 187–187. 5 indexed citations

Bedi, C., et al.. (2011). Comparison of Radiotherapy Treatment Plans for Left-sided Breast Cancer Patients based on Three- and Four-dimensional Computed Tomography Imaging. Clinical Oncology. 23(9). 601–607. 18 indexed citations

Cullinane, Carleen, Athena Hatzimihalis, Cecilia O’Kane, et al.. (2011). Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C14-erythromycin breath test and the antipyrine clearance test. Cancer Chemotherapy and Pharmacology. 69(1). 125–135. 18 indexed citations

10.

Carney, Dennis, David Westerman, Constantine S. Tam, et al.. (2010). Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy. Leukemia. 24(12). 2056–2062. 68 indexed citations

11.

Day, Fiona, Trevor Leong, Sam Ngan, et al.. (2010). Phase I trial of docetaxel, cisplatin and concurrent radical radiotherapy in locally advanced oesophageal cancer. British Journal of Cancer. 104(2). 265–271. 20 indexed citations

12.

Harrison, Simon J., et al.. (2010). Bortezomib and dexamethasone from cycle 1 as treatment and maintenance for multiple myeloma relapse (The BoMeR trial): Impact on response and time to progression.. Journal of Clinical Oncology. 28(15_suppl). 8151–8151. 1 indexed citations

13.

Winton, Emma De, Alexander G. Heriot, Michael Ng, et al.. (2009). The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer. British Journal of Cancer. 100(5). 693–700. 76 indexed citations

14.

Michael, Michael, Timothy Price, Samuel Y. Ngan, et al.. (2008). A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer. British Journal of Cancer. 100(1). 37–43. 4 indexed citations

15.

Heriot, Alexander G., John Mackay, Elizabeth Drummond, et al.. (2008). The Impact of 18-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography on the Staging and Management of Primary Rectal Cancer. Diseases of the Colon & Rectum. 51(7). 997–1003. 39 indexed citations

16.

Mileshkin, Linda, Dirk Hönemann, Peter Gambell, et al.. (2007). Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines, angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome. Haematologica. 92(8). 1075–1082. 29 indexed citations

17.

Wirth, A., et al.. (2007). Radiotherapy for low‐grade gastric marginal zone lymphoma: a retrospective study. Internal Medicine Journal. 37(3). 172–180. 3 indexed citations

18.

Leong, Trevor, Daryl Lim Joon, David J. Willis, et al.. (2007). Adjuvant chemoradiation for gastric cancer using epirubicin, cisplatin, and 5-FU (ECF) before and after 3D- conformal radiotherapy with continuous infusional 5-FU: A multicentre study fo the Trans-Tasman Radiation Oncology Group (TROG). Queensland's institutional digital repository (The University of Queensland). 69. 1 indexed citations

19.

Dawson, Sarah‐Jane, Kian Fong Foo, Michael Jefford, et al.. (2006). A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer. Investigational New Drugs. 25(2). 123–129. 27 indexed citations

20.

Hughes, Stephen, T Justin Clark, A. Milner, et al.. (2000). Serial fetal lung volume measurement using three‐dimensional ultrasound. Ultrasound in Obstetrics and Gynecology. 16(2). 154–158. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact